Thursday 22 April 2021
Home      All news      Contact us      RSS      India
news18 - 2 month ago

Bharat Biotech Announces Phase 3 Results of Covaxin, Says It Shows Interim Efficacy of 81%

Announcing phase three results of coronavirus vaccine Covaxin , Bharat Biotech on Wednesday said that the indigenous shots have demonstrated interim clinical efficacy of 81%.


Latest News
Hashtags:   

Bharat

 | 

Biotech

 | 

Announces

 | 

Phase

 | 

Results

 | 

Covaxin

 | 

Shows

 | 

Interim

 | 

Efficacy

 | 

Sources